Effect of amino acids on the generation of ginsenoside Rg3 epimers by heat processing and the anticancer activities of epimers in A2780 human ovarian cancer cells

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Park, Jun Yeon ^a   Choi, Pilju ^b   Lee, Dahae ^a   Kim, Taejung ^b   Jung, Eun Bee ^a   Hwang, Buyng Su ^b   Kang, Ki Sung ^a   Ham, Jungyeob ^b  

^a Gachon University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; CASPASE 3; CASPASE 8; CASPASE 9; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 3; GINSENOSIDE RG 5; GINSENOSIDE RK 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; VALINE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; EPIMER; FEMALE; FLOW CYTOMETRY; GINSENG; GLYCATION; HEAT; HUMAN; HUMAN CELL; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84962050626     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3146402     Document Type: Article

References (31)

1. L. H. Hurley, "DNA and its associated processes as targets for cancer therapy, " Nature Reviews Cancer, vol. 2, no. 3, pp. 188-200, 2002.
2. Y.-T. Kim, S.-K. Kim, Y.-J. Jeon, and S. J. Park, "Seahorse-derived peptide suppresses invasive migration of HT1080 fibrosarcoma cells by competing with intracellular β-enolase for plasminogen binding and inhibiting uPA-mediated activation of plasminogen, " BMB Reports, vol. 47, no. 12, pp. 691-696, 2014.
3. N. C. Miltenburg and W. Boogerd, "Chemotherapy-induced neuropathy: a comprehensive survey, " Cancer Treatment Reviews, vol. 40, no. 7, pp. 872-882, 2014.
4. N. Yamabe, Y.-J. Kim, S. Lee, et al., "Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Maillard reaction, " Food Chemistry, vol. 138, no. 2-3, pp. 876-883, 2013.
5. Y.-S. Keum, K.-K. Park, J.-M. Lee, et al., "Antioxidant and antitumor promoting activities of the methanol extract of heatprocessed ginseng, " Cancer Letters, vol. 150, no. 1, pp. 41-48, 2000.
6. E.-H. Park, Y.-J. Kim, N. Yamabe, et al., "Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heatprocessed american ginseng on human gastric cancer cell, " Journal of Ginseng Research, vol. 38, no. 1, pp. 22-27, 2014.
7. T. Tode, Y. Kikuchi, T. Kita, J. Hirata, E. Imaizumi, and I. Nagata, "Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice, " Journal of Cancer Research and Clinical Oncology, vol. 120, no. 1-2, pp. 24-26, 1993.
8. T.-K. Yun and S.-Y. Choi, "Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs, " Cancer Epidemiology Biomarkers&Prevention, vol. 4, no. 4, pp. 401-408, 1995.
9. L. Jia, Y. Zhao, and X.-J. Liang, "Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional chinese medicine, " Current Medicinal Chemistry, vol. 16, no. 22, pp. 2924-2942, 2009.
10. K. S. Kang, J. Ham, Y.-J. Kim, J. H. Park, E.-J. Cho, and N. Yamabe, "Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism, " Journal of Ginseng Research, vol. 37, no. 4, pp. 379-388, 2013.
11. T. H. Le, S. Y. Lee, T. R. Kim, et al., "Processed Vietnamese ginseng: preliminary results in chemistry and biological activity, " Journal of Ginseng Research, vol. 38, no. 2, pp. 154-159, 2014.
12. W. Y. Kim, J. M. Kim, S. B. Han, et al., "Steaming of ginseng at high temperature enhances biological activity, " Journal of Natural Products, vol. 63, no. 12, pp. 1702-1704, 2000.
13. K. S. Kang, H. Y. Kim, J. S. Pyo, and T. Yokozawa, "Increase in the free radical scavenging activity of ginseng by heat-processing, " Biological&Pharmaceutical Bulletin, vol. 29, no. 4, pp. 750-754, 2006.
14. B.-G. Park, H.-J. Jung, Y.-W. Cho, H.-W. Lim, and C.-J. Lim, "Potentiation of antioxidative and anti-inflammatory properties of cultured wild ginseng root extract through probiotic fermentation, " Journal of Pharmacy and Pharmacology, vol. 65, no. 3, pp. 457-464, 2013.
15. Y.-J. Kim, W.-I. Choi, B.-N. Jeon, et al., "Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-α1-induced epithelialmesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance, " Toxicology, vol. 322, pp. 23-33, 2014.
16. K. Y. Lee, Y. H. Lee, S. I. Kim, J. H. Park, and S. K. Lee, "Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21Cip/WAF1 and downregulating cyclin E in SK-HEP-1 cells, " Anticancer Research, vol. 17, no. 2, pp. 1067-1072, 1997.
17. Y.-J. Kim, H. C. Kwon, H. Ko, et al., "Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis, " Biological and Pharmaceutical Bulletin, vol. 31, no. 5, pp. 826-830, 2008.
18. H. Ko, Y.-J. Kim, J.-S. Park, J. H. Park, and H. O. Yang, "Autophagy inhibition enhances apoptosis induced by ginsenoside Rkl in hepatocellular carcinoma cells, " Bioscience, Biotechnology and Biochemistry, vol. 73, no. 10, pp. 2183-2189, 2009.
19. X. Li, Y. Zheng, M. Liu, and L. Zhang, "A study on maillard reaction and its products during processing of red ginseng, " Zhongguo Zhong Yao Za Zhi, vol. 24, no. 5, pp. 274-278, 1999.
20. K. S. Kang, H. Y. Kim, J. S. Pyo, and T. Yokozawa, "Increase in the free radical scavenging activity of ginseng by heat-processing, " Biological and Pharmaceutical Bulletin, vol. 29, no. 4, pp. 750-754, 2006.
21. Y.-J. Kim, N. Yamabe, P. Choi, J. W. Lee, J. Ham, and K. S. Kang, "Efficient thermal deglycosylation of ginsenoside Rd and its contribution to the improved anticancer activity of ginseng, " Journal of Agricultural and Food Chemistry, vol. 61, no. 38, pp. 9185-9191, 2013.
22. J. H. Lee, W. Lee, S. Lee, et al., "Important role of Maillard reaction in the protective effect of heat-processed ginsenoside Re-serine mixture against cisplatin-induced nephrotoxicity in LLC-PK1 cells, " Bioorganic andMedicinal Chemistry Letters, vol. 22, no. 17, pp. 5475-5479, 2012.
23. J. Li, K. Jiang, X. Qiu, et al., "Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer, " BMB Reports, vol. 47, no. 1, pp. 33-38, 2014.
24. C. B. Thompson, "Apoptosis in the pathogenesis and treatment of disease, " Science, vol. 267, no. 5203, pp. 1456-1462, 1995.
25. J. Yuan and B. A. Yankner, "Apoptosis in the nervous system, " Nature, vol. 407, no. 6805, pp. 802-809, 2000.
26. M. Brentnall, L. Rodriguez-Menocal, R. L. de Guevara, E. Cepero, and L. H. Boise, "Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis, "BMCCell Biology, vol. 14, article 32, 2013.
27. N. N. Danial and S. J. Korsmeyer, "Cell death: critical control points, " Cell, vol. 116, no. 2, pp. 205-219, 2004.
28. L. Galluzzi, I. Vitale, J. M. Abrams, et al., "Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, " Cell Death and Differentiation, vol. 19, no. 1, pp. 107-120, 2012.
29. D. R. Green, "Apoptotic pathways: the roads to ruin, " Cell, vol. 94, no. 6, pp. 695-698, 1998.
30. A. Hartmann, J.-D. Troadec, S. Hunot, et al., "Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinsons disease, but pathway inhibition results in neuronal necrosis, " Journal of Neuroscience, vol. 21, no. 7, pp. 2247-2255, 2001.
31. M. Tewari, L. T. Quan, K. O'Rourke, et al., "Yama/CPP32, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase, " Cell, vol. 81, no. 5, pp. 801-809, 1995.